China Pharma Holdings Book Value Per Share Growth & History (CPHI)
China Pharma Holdings's book value per share was $4.12 for fiscal 2025.
View full China Pharma Holdings company overviewChina Pharma Holdings annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.12 | $1.74 | +73.37% |
| 2024 | 2024-12-31 | $2.38 | -$4.64 | −66.14% |
| 2023 | 2023-12-31 | $7.02 | -$21.62 | −75.50% |
| 2022 | 2022-12-31 | $28.63 | -$34.93 | −54.95% |
| 2021 | 2021-12-31 | $63.56 | -$24.25 | −27.61% |
| 2020 | 2020-12-31 | $87.81 | -$18.18 | −17.15% |
| 2019 | 2019-12-31 | $105.99 | -$240.49 | −69.41% |
| 2018 | 2018-12-31 | $346.48 | -$147.69 | −29.89% |
| 2017 | 2017-12-31 | $494.17 | -$181.71 | −26.89% |
| 2016 | 2016-12-31 | $675.88 | -$157.55 | −18.90% |
| 2015 | 2015-12-31 | $833.43 | -$230.60 | −21.67% |
| 2014 | 2014-12-31 | $1,064.03 | -$461.28 | −30.24% |
| 2013 | 2013-12-31 | $1,525.31 | -$178.66 | −10.49% |
| 2012 | 2012-12-31 | $1,703.97 | $67.35 | +4.11% |
| 2011 | 2011-12-31 | $1,636.62 | $278.04 | +20.47% |
| 2010 | 2010-12-31 | $1,358.58 | — | — |
China Pharma Holdings quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0.89 | -$1.09 | −54.93% |
| Q1 2026 | 2026-03-31 | $0.91 | -$1.22 | −57.24% |
| Q4 2025 | 2025-12-31 | $4.12 | $1.74 | +73.37% |
| Q3 2025 | 2025-09-30 | $2.55 | -$1.11 | −30.27% |
| Q2 2025 | 2025-06-30 | $1.98 | -$2.34 | −54.11% |
| Q1 2025 | 2025-03-31 | $2.14 | — | — |
| Q4 2024 | 2024-12-31 | $2.38 | -$4.64 | −66.14% |
| Q3 2024 | 2024-09-30 | $3.66 | -$6.98 | −65.64% |
| Q2 2024 | 2024-06-30 | $4.32 | -$21.44 | −83.24% |
| Q4 2023 | 2023-12-31 | $7.02 | -$21.62 | −75.50% |
| Q3 2023 | 2023-09-30 | $10.64 | -$17.46 | −62.14% |
| Q2 2023 | 2023-06-30 | $25.76 | -$15.05 | −36.89% |
| Q1 2023 | 2023-03-31 | $27.63 | -$27.65 | −50.02% |
| Q4 2022 | 2022-12-31 | $28.63 | -$34.93 | −54.95% |
| Q3 2022 | 2022-09-30 | $28.10 | -$44.30 | −61.19% |
| Q2 2022 | 2022-06-30 | $40.81 | -$30.76 | −42.98% |
| Q1 2022 | 2022-03-31 | $55.28 | -$26.94 | −32.76% |
| Q4 2021 | 2021-12-31 | $63.56 | -$24.25 | −27.61% |
| Q3 2021 | 2021-09-30 | $72.40 | -$17.77 | −19.71% |
| Q2 2021 | 2021-06-30 | $71.57 | -$24.79 | −25.72% |
| Q1 2021 | 2021-03-31 | $82.22 | -$13.93 | −14.48% |
| Q4 2020 | 2020-12-31 | $87.81 | -$18.18 | −17.15% |
| Q3 2020 | 2020-09-30 | $90.17 | -$223.70 | −71.27% |
| Q2 2020 | 2020-06-30 | $96.36 | -$236.00 | −71.01% |
| Q1 2020 | 2020-03-31 | $96.14 | -$255.13 | −72.63% |
| Q4 2019 | 2019-12-31 | $105.99 | -$240.49 | −69.41% |
| Q3 2019 | 2019-09-30 | $313.87 | -$117.90 | −27.31% |
| Q2 2019 | 2019-06-30 | $332.35 | -$138.34 | −29.39% |
| Q1 2019 | 2019-03-31 | $351.28 | -$158.73 | −31.12% |
| Q4 2018 | 2018-12-31 | $346.48 | -$147.69 | −29.89% |
| Q3 2018 | 2018-09-30 | $431.77 | -$222.55 | −34.01% |
| Q2 2018 | 2018-06-30 | $470.69 | -$184.92 | −28.21% |
| Q1 2018 | 2018-03-31 | $510.01 | -$160.28 | −23.91% |
| Q4 2017 | 2017-12-31 | $494.17 | -$181.71 | −26.89% |
| Q3 2017 | 2017-09-30 | $654.33 | -$90.69 | −12.17% |
| Q2 2017 | 2017-06-30 | $655.61 | -$112.65 | −14.66% |
| Q1 2017 | 2017-03-31 | $670.29 | -$150.84 | −18.37% |
| Q4 2016 | 2016-12-31 | $675.88 | -$157.55 | −18.90% |
| Q3 2016 | 2016-09-30 | $745.02 | -$179.99 | −19.46% |
| Q2 2016 | 2016-06-30 | $768.26 | -$225.77 | −22.71% |
| Q1 2016 | 2016-03-31 | $821.13 | -$193.78 | −19.09% |
| Q4 2015 | 2015-12-31 | $833.43 | -$230.60 | −21.67% |
| Q3 2015 | 2015-09-30 | $925.01 | -$390.46 | −29.68% |
| Q2 2015 | 2015-06-30 | $994.04 | -$393.65 | −28.37% |
| Q1 2015 | 2015-03-31 | $1,014.91 | -$470.18 | −31.66% |
| Q4 2014 | 2014-12-31 | $1,064.03 | -$461.28 | −30.24% |
| Q3 2014 | 2014-09-30 | $1,315.47 | -$323.57 | −19.74% |
| Q2 2014 | 2014-06-30 | $1,387.69 | -$267.66 | −16.17% |
| Q1 2014 | 2014-03-31 | $1,485.09 | -$196.02 | −11.66% |
| Q4 2013 | 2013-12-31 | $1,525.31 | -$178.66 | −10.49% |
| Q3 2013 | 2013-09-30 | $1,639.04 | -$74.32 | −4.34% |
| Q2 2013 | 2013-06-30 | $1,655.35 | -$44.57 | −2.62% |
| Q1 2013 | 2013-03-31 | $1,681.11 | $1.65 | +0.10% |
| Q4 2012 | 2012-12-31 | $1,703.97 | $67.35 | +4.11% |
| Q3 2012 | 2012-09-30 | $1,713.36 | $132.49 | +8.38% |
| Q2 2012 | 2012-06-30 | $1,699.93 | $194.74 | +12.94% |
| Q1 2012 | 2012-03-31 | $1,679.46 | — | — |
| Q4 2011 | 2011-12-31 | $1,636.62 | $278.04 | +20.47% |
| Q3 2011 | 2011-09-30 | $1,580.87 | — | — |
| Q2 2011 | 2011-06-30 | $1,505.18 | — | — |
| Q4 2010 | 2010-12-31 | $1,358.58 | — | — |
China Pharma Holdings book value per share trends
Over the last five fiscal years, China Pharma Holdings's book value per share decreased from $87.81 to $4.12, a change of -$83.69. The latest reported quarter, Q2 2026, shows $0.89.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review China Pharma Holdings source filings ↗